The 5 key players our Osteoporosis Drugs report profiles, and other companies free public records show in this market.
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 | Amgen Inc. |
amgen.com (opens in a new tab) | 693 reports |
| 2 | Eli Lilly and Company |
lilly.com (opens in a new tab) | 1,056 reports |
| 3 | Radius Health | — | 33 reports |
| 4 | UCB | — | 231 reports |
| 5 | Novartis AG |
novartis.com (opens in a new tab) | 1,551 reports |
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
| Company | Where public records show them |
|---|---|
| AgNovos Healthcare, LLC |
|
Amneal Pharmaceuticals, Inc |
|
| Amber Implants B.V. |
|
| Zydus Lifesciences | |
Aurobindo Pharma |
|
| Mylan N.V. | |
| Qilu Pharmaceutical Co., Ltd. |
|
Apotex Inc |
|
| Wyeth Pharmaceuticals | |
Teva Pharmaceutical |
|
| Novast Laboratories | |
| Barr |
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.
Companies leading the most active studies found with this market's trial search, worldwide (key players included).
Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.